Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

EOI Announces Initial Surgeries With the FLXfit™15, the First Articulated and Expandable Cage With 15 Degrees of Lordosis Correction

Expanding Orthopedics Inc.
Posted on: 26 Oct 17
EOI Announces Initial Surgeries With the FLXfit™15, the First Articulated and Expandable Cage With 15 Degrees of Lordosis Correction FLXfit family expands to provide enhanced performance and versatility

PR Newswire

OR AKIVA, Israel, Oct. 26, 2017

OR AKIVA, Israel, Oct. 26, 2017 /PRNewswire/ --Expanding Orthopedics Inc. (EOI), a privately held medical device company focused on developing and commercializing innovative expandable devices for spine surgery, today announced first surgeries with its enhanced 3D expandable cage, the FLXfit™15.  The FLXfit™15 offers enhanced performance and versatility by providing additional device sizes with the ability to further expand the device up to 4mm to achieve controlled expansion and lordosis correction of up to 15⁰. 

Dr. Marc Weinstein, at the Spine Center at the Florida Orthopaedic Institute in Tampa, FL commented, "EOI's attention to surgeons' feedback and ability to innovate quickly is imperative in this environment". He said, "This new higher range expansion will enable us to better treat our patients and restore segmental lordosis up to 15 degrees. This will have a tremendous impact on our ability to improve the patient's sagittal balance and long-term surgical outcomes." Dr. Weinstein concluded ,"This is an ideal implant for my L5/S1 fusion patients given the reduced size on entry and the need for enhanced lordosis at this level."

Dr. Hamad Farhat, of Chicago, Illinois said, "The new 32mm length option adds great flexibility in treating patients with smaller anatomies as well as higher vertebral levels. The smaller size will allow 15 degrees of lordosis correction with additional space to pack more bone graft material". He explained, "Expandable cages play a key role in successful MIS fusion procedures. The ability to deliver an ALIF type footprint cage with upto 15 degrees of lordosis correction through a minimal, unilateral approach is definitively a paradigm change in the MIS fusion market."

Ofer Bokobza, CEO of Expanding Orthopedics, commented, "We are excited with the first surgeries with the FLXfit™15. This represents our continued commitment for innovation and collaboration with our surgeons to deliver state of the art spine fusion technology designed to improve long term patients' outcome."  He said ,"We believe that the performance and versatility of the new FLXfit™ family will catapult EOI to gain greater share in fusion surgery both in MIS and open approaches."

About Expanding Orthopedics Inc.

Expanding Orthopedics Inc. is medical device company developing and marketing innovative products designed to address unmet clinical needs for spine care and improve long-term patients' outcome. The Company is spearheaded by a seasoned management team, and is advised by a prominent team of spine surgeons. EOI owns a broad patent portfolio around anatomically fit, expandable devices for enhanced stability through a minimally invasive approach.

Contact info:

David Elkaim
VP Marketing and Sales
E-mail: david@xortho.com
Phone: (347) 3219683

 

View original content with multimedia:http://www.prnewswire.com/news-releases/eoi-announces-initial-surgeries-with-the-flxfit15-the-first-articulated-and-expandable-cage-with-15-degrees-of-lordosis-correction-300543882.html

SOURCE Expanding Orthopedics Inc.

PR Newswire
www.prnewswire.com

Last updated on: 26/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.